ATLANTIC trial and feasibility of early administration of ticagrelor in myocardial infarction

Kanorskiĭ, S.G.

Kardiologiia 54(11): 65-69

2014


ISSN/ISBN: 0022-9040
PMID: 25902661
Document Number: 673210
The ATLANTIC trial compared effects of initiation of ticagrelor at the prehospital (ambulance) or hospital (in the catheterization laboratory) stage of treatment of patients with ST-segment elevation myocardial infarction. Initiation of therapy with ticagrelor at prehospital stage short before percutaneous coronary intervention was safe, but did not improve coronary reperfusion before this procedure. However, earlier administration of ticagrelor significantly reduced the risk of stent thrombosis after percutaneous coronary intervention.

Document emailed within 1 workday
Secure & encrypted payments